Evidence map›Paper›PMID 28053536›Full record

ArticleTherapeutics and clinical risk management2017

Identification of a new mutation in an Iranian family with hereditary multiple osteochondromas.

Susan Akbaroghli, Maryam Balali, Behnam Kamalidehghan, Siamak Saber, Omid Aryani, Goh Yong Meng, Massoud Houshmand

Open access · goldAbstract read
In one paragraph

Article in Therapeutics and clinical risk management, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Susan AkbaroghliMofid Children's Hospital, Shahid Beheshti University of Medical Sciences.
Maryam BalaliENT and Head & Neck Research Center and Department, Iran University of Medical Sciences (IUMS).
Behnam KamalidehghanMedical Genetics Department, School of Medicine, Shahid Beheshti University of Medical Sciences; Medical Genetics Department, National Institute for Genetic Engineering and Biotechnology.
Siamak SaberMedical Genetics Department, National Institute for Genetic Engineering and Biotechnology.
Omid AryaniDepartment of Neuroscience, Iran Medical University, Tehran, Iran.
Goh Yong MengDepartment of Veterinary Preclinical Sciences, Faculty of Veterinary Medicine, Universiti Putra Malaysia (UPM), Serdang, Malaysia.
Massoud HoushmandMedical Genetics Department, National Institute for Genetic Engineering and Biotechnology.
Iran University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRUniversiti Putra Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHereditary multiple osteochondromas (HMO), previously named hereditary multiple exostoses (HME), is an autosomal dominant skeletal disorder characterized by the growth of multiple osteochondromas and is associated with bony deformity, skeletal growth reduction, nerve compression, restriction of joint motion, and premature osteoarthrosis. HMO is genetically heterogeneous, localized on at least three chromosomal loci including 8q24.1 ( METHODS AND

resultsThis study was performed on an Iranian family with nine affected individuals from three consecutive generations. Here, the proband was an affected woman who received genetic counseling prior to pregnancy. All exons of the three genes were examined in the proband using polymerase chain reaction and sequencing methods (the last member of this family is a male with severe deformities and lesions, especially around his large joints). Exon 4 of

conclusionThe outcome of this study has extended the genotypic spectrum of Iranian patients with HMO, revealing a way for improving detection and genetic counseling in carriers.

Indexed as

bony exostosesc.1235 G>Aexon 4 of EXT1EXT1 and EXT2hereditary multiple exostosesHMEHMO

Identifiers

PMID28053536
PMCPMC5189706
OpenAlexW2564069680

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.